STATE STREET CORP - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$122,062
-2.1%
52,3870.0%0.00%
Q2 2023$124,681
-31.5%
52,387
-48.3%
0.00%
Q1 2023$181,982
-10.6%
101,247
-5.5%
0.00%
Q4 2022$203,516
+78.5%
107,114
+100.9%
0.00%
Q3 2022$114,000
-25.5%
53,317
-1.1%
0.00%
Q2 2022$153,000
-49.0%
53,927
-25.0%
0.00%
Q1 2022$300,000
-62.1%
71,900
-52.8%
0.00%
Q4 2021$791,000
+143.4%
152,372
+207.4%
0.00%
Q3 2021$325,000
+122.6%
49,566
+125.1%
0.00%
Q2 2021$146,000
+13.2%
22,019
-2.3%
0.00%
Q1 2021$129,000
-35.8%
22,5340.0%0.00%
Q4 2020$201,000
-28.7%
22,534
-7.1%
0.00%
Q3 2020$282,000
+55.8%
24,267
+115.4%
0.00%
Q2 2020$181,000
+154.9%
11,268
-4.9%
0.00%
Q1 2020$71,000
-57.7%
11,844
-6.8%
0.00%
Q4 2019$168,000
+5.0%
12,708
-1.5%
0.00%
Q3 2019$160,00012,9000.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders